Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Cook

Showing results (181-190 of 194) with videos related to

Pageof 20
Sort By:
Ebiomedicine|November 28, 2025
Common and rare variant analyses reveal genetic factors underlying idiopathic pulmonary fibrosis and its shared aetiology with severe COVID-19Athanasios Kousathanas, Christopher A Odhams, James Cook, et al.
Nature Biotechnology|January 24, 2006
Optimization of humanized IgGs in glycoengineered Pichia pastorisHuijuan Li, Natarajan Sethuraman, Terrance A Stadheim, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2005
4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17beta-hydroxysteroid dehydrogenase. Part 2. SARDavid Gunn, Christiana Akuche, Jeremy Baryza, et al.
Cerebral Cortex (New York, N.Y. : 1991)|March 24, 2016
eEF2K/eEF2 Pathway Controls the Excitation/Inhibition Balance and Susceptibility to Epileptic SeizuresChristopher Heise, Elham Taha, Luca Murru, et al.
Science Translational Medicine|June 12, 2024
Anti-PD-1 cancer immunotherapy induces central nervous system immune-related adverse events by microglia activationJanaki Manoja Vinnakota, Rachael C Adams, Dimitrios Athanassopoulos, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 6, 2005
A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitopeMichael D Miller, Romas Geleziunas, Elisabetta Bianchi, et al.
Journal of Medicinal Chemistry|December 14, 2016
Design and Synthesis of a New Series of 4-Heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes as α7 Nicotinic Receptor Agonists. 1. Development of Pharmacophore and Early Structure-Activity RelationshipJames Cook, F Christopher Zusi, Ivar M McDonald, et al.
The Journal of Experimental Medicine|July 8, 2025
Gut microbiota-derived TMAVA is a modulator of acute CNS-GVHDSangya Chatterjee, Tamina Rückert, Ina Martin, et al.
Plos One|April 23, 2021
Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US VeteransCatherine G Derington, Jordana B Cohen, April F Mohanty, et al.
Infection and Immunity|March 23, 2006
A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis modelNelly A Kuklin, Desmond J Clark, Susan Secore, et al.
Pageof 20

Showing results (181-190 of 194) with videos related to

Sort By:
Pageof 20
Ebiomedicine|November 28, 2025
Common and rare variant analyses reveal genetic factors underlying idiopathic pulmonary fibrosis and its shared aetiology with severe COVID-19Athanasios Kousathanas, Christopher A Odhams, James Cook, et al.
Nature Biotechnology|January 24, 2006
Optimization of humanized IgGs in glycoengineered Pichia pastorisHuijuan Li, Natarajan Sethuraman, Terrance A Stadheim, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2005
4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17beta-hydroxysteroid dehydrogenase. Part 2. SARDavid Gunn, Christiana Akuche, Jeremy Baryza, et al.
Cerebral Cortex (New York, N.Y. : 1991)|March 24, 2016
eEF2K/eEF2 Pathway Controls the Excitation/Inhibition Balance and Susceptibility to Epileptic SeizuresChristopher Heise, Elham Taha, Luca Murru, et al.
Science Translational Medicine|June 12, 2024
Anti-PD-1 cancer immunotherapy induces central nervous system immune-related adverse events by microglia activationJanaki Manoja Vinnakota, Rachael C Adams, Dimitrios Athanassopoulos, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 6, 2005
A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitopeMichael D Miller, Romas Geleziunas, Elisabetta Bianchi, et al.
Journal of Medicinal Chemistry|December 14, 2016
Design and Synthesis of a New Series of 4-Heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes as α7 Nicotinic Receptor Agonists. 1. Development of Pharmacophore and Early Structure-Activity RelationshipJames Cook, F Christopher Zusi, Ivar M McDonald, et al.
The Journal of Experimental Medicine|July 8, 2025
Gut microbiota-derived TMAVA is a modulator of acute CNS-GVHDSangya Chatterjee, Tamina Rückert, Ina Martin, et al.
Plos One|April 23, 2021
Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US VeteransCatherine G Derington, Jordana B Cohen, April F Mohanty, et al.
Infection and Immunity|March 23, 2006
A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis modelNelly A Kuklin, Desmond J Clark, Susan Secore, et al.
Pageof 20